Ihuman Inc
$ 1.72
0.52%
24 Feb - close price
- Market Cap 88,257,000 USD
- Current Price $ 1.72
- High / Low $ 1.72 / 1.67
- Stock P/E 6.14
- Book Value 2.79
- EPS 0.28
- Next Earning Report 2026-03-24
- Dividend Per Share N/A
- Dividend Yield 4.31 %
- Next Dividend Date -
- ROA 0.03 %
- ROE 0.11 %
- 52 Week High 3.60
- 52 Week Low 1.67
About
iHuman Inc. provides children's entertainment products and services to individual users, educational organizations and distributors in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.
Analyst Target Price
$3.86
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-12-18 | 2025-09-18 | 2025-06-26 | 2025-03-26 | 2024-12-05 | 2024-09-19 | 2024-06-28 | 2024-02-29 | 2023-12-28 | 2023-09-21 | 2023-06-21 | 2023-03-31 |
| Reported EPS | 0.0564 | 0.6 | 0.49 | 0.5 | 0.0649 | 0.0627 | 0.0567 | 0.0841 | 0.73 | 0.77 | 0.0921 | 0.66 |
| Estimated EPS | 0 | 0 | None | None | None | None | 0.41 | 0.61 | 0.73 | 0.77 | 0.99 | 0.4754 |
| Surprise | 0.0564 | 0.6 | 0 | 0 | 0 | 0 | -0.3533 | -0.5259 | 0 | 0 | -0.8979 | 0.1846 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | -86.1707% | -86.2131% | 0% | 0% | -90.697% | 38.8305% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-24 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | |
| Currency | USD |
Previous Dividend Records
| May 2025 | May 2024 | |
|---|---|---|
| Payment Date | 2025-05-15 | 2024-05-15 |
| Amount | $0.1 | $0.1 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: IH
2026-02-13 14:27:37
Short interest in iHuman Inc. Sponsored ADR (NYSE:IH) dramatically increased by 92.4% in January, reaching 6,529 shares. This rise coincides with a negative shift in analyst sentiment, including a downgrade to "Sell" by Weiss Ratings and a consensus "Sell" rating from MarketBeat. Despite institutional investment from Acadian Asset Management, the stock's market capitalization stands at approximately $100.6 million with a low days-to-cover ratio of 0.3.
2026-02-13 03:27:37
iHuman (NYSE:IH) has shown a decline in its Return on Capital Employed (ROCE) over the past five years, dropping from 25% to 7.3%. Despite increasing capital utilization, sales have not significantly improved, suggesting that recent investments may not be yielding high returns. Investors are cautioned as the stock has fallen 89% over the same period, indicating a lack of confidence in the company's long-term growth prospects.
2026-01-01 11:09:21
iHuman Inc. (NYSE:IH) has seen its stock price drop by 26% in the last month, yet it is still up 25% over the past year. Despite a low P/E ratio of 7.1x, which might suggest a strong buy compared to the broader U.S. market, the article cautions that the low ratio could indicate investor concerns about the company's ability to maintain its recent earnings growth. Although iHuman's earnings have grown respectably, outperforming market expectations, the P/E ratio suggests skepticism about the sustainability of this performance.
2026-01-01 02:10:08
iHuman Inc. (NYSE:IH) has seen its share price drop by 26% in the last month, yet it is still up 25% over the past year. Despite a low P/E ratio of 7.1x compared to the broader market, investors seem hesitant, possibly due to concerns about the sustainability of its recent earnings growth. Although iHuman's earnings have grown respectably, outperforming market expectations, the low P/E suggests that many investors anticipate future instability.
2025-12-30 18:57:40
iHuman (IH) reported a decrease in Q3 2025 revenue to RMB205.8 million from RMB239.4 million year-over-year, alongside a reduction in gross profit, operating income, and net income, attributed to a shrinking newborn population and weaker consumer spending in China. Despite these challenges, the company maintained its 15th consecutive quarter of profitability with a strong gross margin of 68.3% and expanded its AI learning ecosystem with new products like the iHuman AI Pal and integrations into smart speaker platforms and vehicles. Analysts currently rate IH stock as a "Hold" with a $3.00 price target, noting the company's strong valuation and financial stability counterbalance its growth and profitability challenges.
2025-12-30 16:09:31
iHuman Inc. (IH) reported a decrease in Q3 2025 revenues and average total MAUs, attributed to a shrinking newborn population and weaker consumer spending in China. Despite these challenges, the company maintained its 15th consecutive quarter of profitability, a strong gross margin, and a significant cash reserve, while continuing strategic investments in product innovation and AI-powered learning initiatives. Spark, TipRanks’ AI Analyst, rates IH stock as Neutral due to strong valuation and financial stability, tempered by growth challenges and a slightly bearish technical trend.
